Effects of the Clinical Application of Traditional, Complementary and Integrative Medicine (TCIM) Procedures During Inpatient Stays in Germany

ConditionChronic Disease

Trial statusRecruiting

Trial phaseNot listed

Trial typeObservational

Biological sexAll

Age18+

SponsorCharite University, Berlin, Germany

About this trial

The aim of this healthcare research project is to evaluate the effects of routine inpatient TCIM (Traditional, Complementary and Integrative Medicine) care in Germany. The focus is on the TCIM centers at Immanuel Krankenhaus Berlin, Klinikum Bamberg und Evang. Kliniken Essen-Mitte, where inpatient TCIM therapies are to be systematically evaluated. This form of therapy, which is reimbursed by statutory health insurance providers (under certain conditions), is based on a combination of various evidence-based TCIM approaches. These include hyperthermia, exercise therapy, Mind-Body Medicine, phytotherapy, nutritional therapy, fasting therapy inter alia.

Eligibility criteria

This trial does not accept healthy volunteers

Qualifiers

Beginning (first 24 hours) inpatient TCIM treatment at Immanuel Hospital Berlin, Bamberg Hospital, or Evangelische Kliniken Essen-Mitte

Written consent form

Disqualifiers

Insufficient language skills

Dementia or other severely impairing cognitive disorders

Pregnancy or breastfeeding

Participation in a clinical study

Trial population

All patients in TCIM wards are offered the opportunity to participate in this study.

Trial design

Design model

Cohort

Time perspective

Prospective

Treatments tested in this trial

Inpatient TCIM therapy
Other intervention
This multicenter, prospective, uncontrolled observational study is evaluating the effects and safety of inpatient TCIM therapy (German: naturheilkundliche Komplextherapie) at three German clinics: Immanuel Hospital Berlin, Klinikum Bamberg, and Evangelical Clinics Essen-Mitte. This therapy, reimbursed by statutory health insurance under certain conditions, combines evidence-informed TCIM approaches such as hyperthermia, exercise therapy, phytotherapy, and dietary interventions including fasting i.a.

Treatment groups

2,500 Participants

are divided into 1 treatment group

Group A: TCIM1 intervention

Trial outcomes

Primary outcomes

Short Form Health Survey - 12 Items (SF-12)

0-100, higher scores indicate better health status.

Time frame

Baseline, 3 months

Secondary outcomes

Short Form Health Survey - 12 Items (SF-12)

0-100, higher scores indicate better health status.

Time frame

Baseline, up to 14 days, 6 months, 12 months

EuroQol 5-Dimension 5-Level

0 (worst) to 1 (best), higher scores indicate better health-related quality of life.

Time frame